Amie J Goodin, Ph.D.
Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 294-8829
Business Email:
amie.goodin@ufl.edu
About Amie J Goodin
Dr. Goodin is an Assistant Professor within the Department of Pharmaceutical Outcomes and Policy (POP) and the Center for Drug Evaluation and Safety (CoDES). She received her Master of Public Policy degree from the University of Kentucky (UK). She completed her Doctor of Philosophy degree at UK’s Martin School of Public Policy, with specialization in pharmaceutical outcomes and an additional Certificate in Informatics. She completed a Postdoctoral Fellowship at University of Florida POP, specializing in pharmacoepidemiology methods while continuing her work in Health Services Research. She is the lead for Health Services Research track within POP’s graduate program as well as the faculty lead for Research Strategy within the Consortium for Medical Marijuana Clinical Outcomes Research. Currently, her research projects incorporate mixed-method approaches to assess the impact of policy changes related to treatment access and utilization for Substance Use Disorders, particularly among persons enrolled in Medicaid and pregnant women.
Teaching Profile
Courses Taught
2020-2024
PHA5226C Pt Safety and Quality
2020-2022
PHA7979 Advanced Research
2020-2021
PHA6910 Supervised Research
2020-2022
PHA7980 Research for Doctoral Dissertation
2019-2024
PHA5007 Pharm and Pop Health
2020-2021
PHA6971 Research for Master’s Thesis
2020-2024
PHA6717 Measurement in Pharmaceutical Outcomes and Policy Research
2019,2021-2024
PHA5789C Patient Care 7
2021
PHA6940 Supervised Teaching
2021-2024
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6937 Topics in Pharmaceutical Administration
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021
PHA6894 Introduction to Graduate Studies
2024
PHA4910 Undergraduate Research in Pharmaceutical Outcomes and Policy
Research Profile
Areas of Interest
- Health Policy
- Health disparities and vulnerable populations
- Maternal and Child Health
- Substance Use Disorders
- health services research
Open Researcher and Contributor ID (ORCID)
0000-0002-0020-8720
Publications
2024
303 Analyzing the utility of ecological momentary assessment in the evaluation of postpartum depression
American Journal of Obstetrics and Gynecology.
230(1):S173-S174
[DOI] 10.1016/j.ajog.2023.11.325.
2024
785 Utilizing ecological momentary assessment in the postpartum evaluation of patients with hypertensive disorders of pregnancy
American Journal of Obstetrics and Gynecology.
230(1)
[DOI] 10.1016/j.ajog.2023.11.810.
2024
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
Pharmacoepidemiology and Drug Safety.
33(8)
[DOI] 10.1002/pds.5861.
2024
An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals
Computers in Biology and Medicine.
177
[DOI] 10.1016/j.compbiomed.2024.108493.
2024
Cannabis Hyperemesis Syndrome: What Do We Know?
Medical Cannabis and Cannabinoids.
7(1):1-1
[DOI] 10.1159/000539182.
[PMID] 39015607.
2024
End-of-Life Healthcare Utilization in Lewy Body Dementia.
Journal of Alzheimer's disease : JAD.
101(1):133-145
[DOI] 10.3233/JAD-240194.
[PMID] 39121116.
2024
Injurious Fall Risk Differences Among Older Adults With First-Line Depression Treatments.
JAMA network open.
7(8)
[DOI] 10.1001/jamanetworkopen.2024.35535.
[PMID] 39186265.
2024
Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient
Cannabis and Cannabinoid Research.
[DOI] 10.1089/can.2024.0073.
2024
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment
Pharmacoepidemiology and Drug Safety.
33(8)
[DOI] 10.1002/pds.5852.
[PMID] 39099262.
2024
Trajectories of Adherence to Oral Preexposure Prophylaxis (PrEP) and Risks of HIV and Sexually Transmitted Infections
Open Forum Infectious Diseases.
[DOI] 10.1093/ofid/ofae569.
2024
Trajectories of Pre-exposure Prophylaxis Adherence Among Commercially Insured Individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
78(5):1272-1275
[DOI] 10.1093/cid/ciad756.
[PMID] 38066587.
2024
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry
Pharmacoepidemiology and Drug Safety.
33(4)
[DOI] 10.1002/pds.5789.
2023
A Natural Language Processing Algorithm for Classifying Suicidal Behaviors in Alzheimer’s Disease and Related Dementia Patients: Development and Validation Using Electronic Health Records Data.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2023.07.21.23292976.
[PMID] 37546764.
2023
Acceptability of an mHealth App for Monitoring Perinatal and Postpartum Mental Health: Qualitative Study With Women and Providers
JMIR Formative Research.
7
[DOI] 10.2196/44500.
[PMID] 37285185.
2023
Cannabis Effects on Driving Performance: Clinical Considerations.
Medical cannabis and cannabinoids.
6(1):8-14
[DOI] 10.1159/000528714.
[PMID] 36814685.
2023
Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain.
Medical cannabis and cannabinoids.
6(1):41-45
[DOI] 10.1159/000530251.
[PMID] 37124080.
2023
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States.
Preventive medicine reports.
32
[DOI] 10.1016/j.pmedr.2023.102138.
[PMID] 36865395.
2023
Enhancing active learning of medication errors in the PharmD curriculum through a multi-perspective video-based experience.
Currents in pharmacy teaching & learning.
15(3):258-265
[DOI] 10.1016/j.cptl.2023.03.009.
[PMID] 37029078.
2023
Incident mental health episodes after initiation of gabapentinoids vs. dopamine agonists for early-onset idiopathic restless legs syndrome.
Psychiatry research.
328
[DOI] 10.1016/j.psychres.2023.115479.
[PMID] 37708806.
2023
Partnering with recovery community centers to build recovery capital by improving access to reproductive health.
Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
55(3):692-700
[DOI] 10.1111/jnu.12836.
[PMID] 36345125.
2023
Pragmatic Model and Faculty Toolkit for PharmD Student Engagement in Social and Administrative Pharmacy Research.
American journal of pharmaceutical education.
87(5)
[DOI] 10.1016/j.ajpe.2023.02.006.
[PMID] 37288693.
2023
Proceedings of the 2023 Cannabis Clinical Outcomes Research Conference.
Medical cannabis and cannabinoids.
6(1):97-101
[DOI] 10.1159/000533943.
[PMID] 37900895.
2023
Protocol of a Combined Cohort and Cross-Sectional Study of Persons Receiving Medical Cannabis in Florida, USA: The Medical Marijuana and Me (M3) Study.
Medical cannabis and cannabinoids.
6(1):46-57
[DOI] 10.1159/000530052.
[PMID] 37261066.
2023
Risk of preterm delivery and small for gestational age among women with inflammatory bowel disease using tumor necrosis factor alpha inhibitors during pregnancy.
American journal of obstetrics and gynecology.
228(4):474-476
[DOI] 10.1016/j.ajog.2022.12.303.
[PMID] 36565900.
2023
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States
Pharmacoepidemiology and Drug Safety.
32(5):509-516
[DOI] 10.1002/pds.5606.
2022
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
JAMA health forum.
3(6)
[DOI] 10.1001/jamahealthforum.2022.1757.
[PMID] 35977240.
2022
Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.
Journal of general internal medicine.
37(8):1838-1844
[DOI] 10.1007/s11606-021-06966-4.
[PMID] 34236602.
2022
Clinical Considerations for Cannabis Use and Cardiovascular Health
Medical Cannabis and Cannabinoids.
5(1):120-127
[DOI] 10.1159/000526731.
[PMID] 36467784.
2022
Co-utilization of opioids and nonbenzodiazepine hypnotic drugs in U.S. ambulatory care visits, 2006–2016
Journal of the American Pharmacists Association.
62(2):468-474.e2
[DOI] 10.1016/j.japh.2021.10.020.
2022
Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN.
17(6):851-860
[DOI] 10.2215/CJN.14361121.
[PMID] 35589388.
2022
Predictive Modeling for Suicide-Related Outcomes and Risk Factors among Patients with Pain Conditions: A Systematic Review
Journal of Clinical Medicine.
11(16)
[DOI] 10.3390/jcm11164813.
[PMID] 36013053.
2022
Prescription Patterns of Adjuvant Pain Medications Following an Opioid Supply Restriction Law An Interrupted Time Series Analysis
Medical Care.
60(6):432-436
[DOI] 10.1097/MLR.0000000000001719.
2022
Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference
Medical Cannabis and Cannabinoids.
5(1):138-141
[DOI] 10.1159/000527080.
[PMID] 36467782.
2022
The U.S. COVID-19 County Policy Database: a novel resource to support pandemic-related research.
BMC public health.
22(1)
[DOI] 10.1186/s12889-022-14132-6.
[PMID] 36217102.
2022
Tobacco use and mental health disparities in LGB youth
Public Health Nursing.
39(3):659-663
[DOI] 10.1111/phn.12997.
2022
Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome
Sleep Medicine.
96:70-78
[DOI] 10.1016/j.sleep.2022.05.003.
[PMID] 35605349.
2022
Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?
Medical Cannabis and Cannabinoids.
5(1):32-35
[DOI] 10.1159/000522472.
[PMID] 35702401.
2021
A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness
The Lancet Regional Health – Americas.
3
[DOI] 10.1016/j.lana.2021.100075.
[PMID] 36777402.
2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
Medical Cannabis and Cannabinoids.
4(1):21-42
[DOI] 10.1159/000515069.
[PMID] 34676348.
2021
A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug-drug Interactions.
Epidemiology (Cambridge, Mass.).
32(2):268-276
[DOI] 10.1097/EDE.0000000000001302.
[PMID] 33196560.
2021
A survey assessment of clinician perceptions of opioid supply and monitoring requirement policy changes
Journal of Opioid Management.
17(4):337-342
[DOI] 10.5055/jom.2021.0666.
2021
Cannabis use assessment and documentation in healthcare: Priorities for closing the gap.
Preventive medicine.
153
[DOI] 10.1016/j.ypmed.2021.106798.
[PMID] 34506820.
2021
Changes in Quantity of Opioids Dispensed following Florida’s Restriction Law for Acute Pain Prescriptions
Pain Medicine.
22(8):1870-1876
[DOI] 10.1093/pm/pnab017.
[PMID] 33502536.
2021
Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida’s Acute Pain Opioid Restriction Law.
Journal of managed care & specialty pharmacy.
27(6):779-784
[DOI] 10.18553/jmcp.2021.27.6.779.
[PMID] 34057389.
2021
Chronic Opioid Therapy Utilization Following an Acute Pain Prescription Supply Restriction Law: An Interrupted Time Series Analysis.
Pain physician.
24(6):417-424
[PMID] 34554682.
2021
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain.
22(3):246-262
[DOI] 10.1016/j.jpain.2020.09.002.
[PMID] 33031943.
2021
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA.
61(2):e20-e44
[DOI] 10.1016/j.japh.2020.09.013.
[PMID] 33127312.
2021
Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation
Medical Cannabis and Cannabinoids.
4(1):63-66
[DOI] 10.1159/000514732.
[PMID] 34676351.
2021
Framework for Advancing Epidemiological Criminology Research on Prescription Drug Monitoring Programs
American Journal of Criminal Justice.
46(4):665-681
[DOI] 10.1007/s12103-021-09632-x.
2021
Introducing Commentary Series: “Evidence in Context”
Medical Cannabis and Cannabinoids.
4(1):61-62
[DOI] 10.1159/000512684.
[PMID] 34676350.
2021
Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit
Medical Cannabis and Cannabinoids.
4(2):121-124
[DOI] 10.1159/000517154.
[PMID] 35224432.
2021
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions.
Journal of clinical pharmacology.
61 Suppl 2:S37-S52
[DOI] 10.1002/jcph.1871.
[PMID] 34396558.
2021
Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs
Medicine.
100(1)
[DOI] 10.1097/md.0000000000024268.
2021
Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016.
Psychiatric services (Washington, D.C.).
72(11):1246-1253
[DOI] 10.1176/appi.ps.202000338.
[PMID] 34015964.
2021
Perinatal Cannabis Exposures and Autism Spectrum Disorders
Medical Cannabis and Cannabinoids.
4(1):67-71
[DOI] 10.1159/000515871.
[PMID] 34676352.
2021
Priorities for Medical Marijuana Research from the Perspective of Physicians, Dispensary Owners/Staff, and Patients: A Survey Study
Medical Cannabis and Cannabinoids.
4(2):107-113
[DOI] 10.1159/000518105.
[PMID] 35224430.
2021
Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference
Medical Cannabis and Cannabinoids.
4(2):143-146
[DOI] 10.1159/000519037.
[PMID] 35224433.
2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
JAMA network open.
4(6)
[DOI] 10.1001/jamanetworkopen.2021.13383.
[PMID] 34115125.
2020
Appalachian disparities in tobacco cessation treatment utilization in Medicaid
Substance Abuse Treatment, Prevention, and Policy.
15(1)
[DOI] 10.1186/s13011-020-0251-0.
[PMID] 31959212.
2020
Assessing the utility of the Healthy Start Screen to predict an elevated Edinburgh Postnatal Depression Scale score.
Journal of perinatal medicine.
48(5):483-487
[DOI] 10.1515/jpm-2019-0472.
[PMID] 32286250.
2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open.
3(2)
[DOI] 10.1001/jamanetworkopen.2020.0234.
[PMID] 32108887.
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
Journal of Clinical Medicine.
9(4)
[DOI] 10.3390/jcm9041166.
[PMID] 32325769.
2020
Domperidone prescribing patterns in pediatric patients before and after safety warning in South Korea.
International journal of clinical pharmacology and therapeutics.
58(12):687-695
[DOI] 10.5414/CP203688.
[PMID] 32831161.
2020
Healthcare Utilization and Physical Functioning in Older Adults in the United States
Journal of the American Geriatrics Society.
68(2):266-271
[DOI] 10.1111/jgs.16260.
2020
Impact of an on-site perinatal mood disorders clinic in the diagnosis and management of perinatal mood disorders.
Journal of perinatal medicine.
48(8):837-843
[DOI] 10.1515/jpm-2020-0036.
[PMID] 32764166.
2020
Increased Tdap and Influenza Vaccination Acquisition Among Patients Participating in Group Prenatal Care.
The journal of primary prevention.
41(5):413-420
[DOI] 10.1007/s10935-020-00606-z.
[PMID] 32889665.
2020
OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome.
Research in social & administrative pharmacy : RSAP.
16(12):1789-1791
[DOI] 10.1016/j.sapharm.2020.03.010.
[PMID] 32265114.
2020
Perception of prescription drug monitoring programs as a prevention tool in primary medical care.
Research in social & administrative pharmacy : RSAP.
16(9):1306-1308
[DOI] 10.1016/j.sapharm.2019.03.012.
[PMID] 30935769.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014
Journal of Psychosomatic Obstetrics & Gynecology.
1-7
[DOI] 10.1080/0167482x.2020.1727882.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014
Journal of Psychosomatic Obstetrics & Gynecology.
1-7
[DOI] 10.1080/0167482x.2020.1727882.
2019
Mental health disparities and high‐risk alcohol use among non‐heterosexual high school students
Perspectives in Psychiatric Care.
55(4):570-575
[DOI] 10.1111/ppc.12394.
2019
Perinatal Navigator Approach to Smoking Cessation for Women With Prevalent Opioid Dependence.
Western journal of nursing research.
41(8):1103-1120
[DOI] 10.1177/0193945918825381.
[PMID] 30724661.
2019
Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Pharmacotherapy.
39(10):1005-1011
[DOI] 10.1002/phar.2315.
[PMID] 31361913.
2019
Substance Use and School Characteristics in Lesbian, Gay, Bisexual, and Heterosexual High School Students.
The Journal of school health.
89(3):219-225
[DOI] 10.1111/josh.12731.
[PMID] 30637738.
2019
The prevalence of drivers under the influence of medical cannabis must be considered within proper context.
Research in social & administrative pharmacy : RSAP.
15(11):1372-1373
[DOI] 10.1016/j.sapharm.2019.01.015.
[PMID] 30709730.
2018
A Review of Interventions to Increase Vena Cava Filter Retrieval Rates.
Annals of vascular surgery.
51:284-297
[DOI] 10.1016/j.avsg.2018.02.010.
[PMID] 29655810.
2018
Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care.
Vascular medicine (London, England).
23(4):365-371
[DOI] 10.1177/1358863X18768685.
[PMID] 29781388.
2018
Mass Casualty Shooting Venues, Types of Firearms, and Age of Perpetrators in the United States, 1982-2018.
American journal of public health.
108(10):1385-1387
[DOI] 10.2105/AJPH.2018.304584.
[PMID] 30138068.
2018
Patient and hospital characteristics predictive of inferior vena cava filter usage in venous thromboembolism patients: A study from the 2013 to 2014 Nationwide Readmissions Database.
Medicine.
97(12)
[DOI] 10.1097/MD.0000000000010149.
[PMID] 29561421.
2018
Pharmacists’ role in harm reduction: a survey assessment of Kentucky community pharmacists’ willingness to participate in syringe/needle exchange
Harm Reduction Journal.
15(1)
[DOI] 10.1186/s12954-018-0211-4.
[PMID] 29370808.
2018
Rapid Expansion of the Opioid Ecosystem: National Implications for Prescriber–Pharmacist Communication
American Journal of Preventive Medicine.
55(5):656-661
[DOI] 10.1016/j.amepre.2018.05.003.
2018
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Journal of the American Heart Association.
7(6)
[DOI] 10.1161/JAHA.117.007901.
[PMID] 29514808.
2018
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.
34(1):6-13
[DOI] 10.1111/jrh.12251.
[PMID] 28685864.
2018
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment
Journal of Thrombosis and Haemostasis.
16(12):2537-2539
[DOI] 10.1111/jth.14301.
2018
We Cannot Treat the Dead.
American journal of public health.
108(10):1286-1288
[DOI] 10.2105/AJPH.2018.304658.
[PMID] 30207778.
2017
An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents.
BMC geriatrics.
17(1)
[DOI] 10.1186/s12877-017-0690-2.
[PMID] 29282013.
2017
Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing.
Journal of the American Pharmacists Association : JAPhA.
57(2S):S28-S33
[DOI] 10.1016/j.japh.2016.12.064.
[PMID] 28139459.
2017
The Power and Pitfalls of Big Data Research in Obstetrics and Gynecology: A Consumer’s Guide.
Obstetrical & gynecological survey.
72(11):669-682
[DOI] 10.1097/OGX.0000000000000504.
[PMID] 29164265.
2016
Smoking Cessation Awareness and Utilization Among Lesbian, Gay, Bisexual, and Transgender Adults: An Analysis of the 2009-2010 National Adult Tobacco Survey.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
18(4):496-500
[DOI] 10.1093/ntr/ntv103.
[PMID] 26014455.
2015
Menthol cigarette smoking among lesbian, gay, bisexual, and transgender adults.
American journal of preventive medicine.
48(1):93-7
[DOI] 10.1016/j.amepre.2014.07.044.
[PMID] 25245795.
2015
Online medical care: the current state of “eVisits” in acute primary care delivery.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
21(2):90-6
[DOI] 10.1089/tmj.2014.0022.
[PMID] 25474083.
2015
Prescription drug monitoring program utilization in Kentucky community pharmacies.
Pharmacy practice.
13(2)
[PMID] 26131042.
2015
Smoking characteristics among lesbian, gay, and bisexual adults.
Preventive medicine.
74:123-30
[DOI] 10.1016/j.ypmed.2014.11.026.
[PMID] 25485860.
2014
Kentucky pharmacists’ opinions of the potential reclassification of pseudoephedrine as a legend drug.
Journal of the American Pharmacists Association : JAPhA.
54(4):397-405
[DOI] 10.1331/JAPhA.2014.13177.
[PMID] 25063261.
2014
Smoke-free policy implementation: theoretical and practical considerations.
Policy, politics & nursing practice.
15(3-4):81-92
[DOI] 10.1177/1527154414562301.
[PMID] 25573743.
2012
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population.
Pain physician.
15(3 Suppl):ES169-75
[PMID] 22786455.
Grants
Jul 2023
– Jun 2024
Reducing Maternal Morbidity & Mortality with Gator MOMitor Year 3
Role: Co-Project Director/Principal Investigator
Funding: FL DEPT OF HLTH
Jan 2023
– Aug 2023
Medical Literature and Data on Cannabis Use
Role: Principal Investigator
Funding: HARVARD PILGRIM HEALTHCARE
via US FOOD AND DRUG ADMN
Jul 2022
– Jun 2023
Reducing Maternal Morbidity and Mortality with Gator MOMitor
Role: Co-Investigator
Funding: FL DEPT OF HLTH
Aug 2021
– Aug 2022
Applying big data to improve mental health outcomes with restless legs syndrome treatment
Role: Other
Funding: NATL INST OF HLTH NIMH
Jul 2021
– Jun 2022
Reducing Maternal Morbidity and Mortality in the Covid-19 Era and Beyond
Role: Co-Investigator
Funding: FL DEPT OF HLTH
Apr 2021
– Mar 2022
Opioid Disposal in Post-Surgical Patients Using an At-Home Drug Disposal Delivery System
Role: Principal Investigator
Funding: RX ABUSE LEADERSHIP INITIATIVE
Jan 2021
– Dec 2022
Program Evaluation and Analytic Support Services for a Substance Use Disorders Recovery Community Center
Role: Principal Investigator
Funding: VOICES OF HOPE
via NATL INST OF HLTH NIDA
Jan 2020
– Feb 2021
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Co-Investigator
Funding: AMER ASSO OF COL OF PHARMACY
Aug 2019
– Dec 2020
Program Evaluation and Analytic Support Services for a Substance Use Disorders Recovery Community Center
Role: Principal Investigator
Funding: VOICES OF HOPE
Apr 2019
– Apr 2020
Evaluating Learning Outcomes in Continuing Pharmacy and Medical Education
Role: Principal Investigator
Funding: CREATIVE EDUCATIONAL CONCEPTS
Mar 2017
– Jun 2020
All-cause readmission measures on inpatient psychiatry facilities
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Education
Ph.D.
2015
·
University of Kentucky
M.P.P.
2009
·
University of Kentucky
B.S.
2007
·
University of Kentucky
Contact Details
Phones:
- Business:
- (352) 294-8829
Emails:
- Business:
- amie.goodin@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
HPNP 3319
GAINESVILLE FL 326103007
Recent news
New Florida law leads to decline in opioid use, according to UF study
UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.
UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
Dr. Amie Goodin featured in NY Times story on the opioid crisis
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
We Cannot Treat the Dead
Assistant Scientist Amie Goodin, Ph.D., publishes an editorial in the American Journal of Public Health on the opioid epidemic.